Att 2a_60d FRN

10810

Federal Register / Vol. 79, No. 38 / Wednesday, February 26, 2014 / Notices

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04136 Filed 2–25–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14KE]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an email to [email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
A Comprehensive Evaluation of a
Paid Social Media and Mass Media
Gynecologic Cancer Campaign—New—

cancer, (2) cost of mass media
advertising, (3) size of the target
audience in the city, (4) similarity in
population size and demographics, and
(5) previous Inside Knowledge
campaign activities within the city. The
two locations selected for this
evaluation study will fall within the
Nielsen 35–45 Designated Market Area
(DMA) designations. The additional
campaign advertising will include
digital media and traditional media that
will be implemented in flights,
including the following: (1) A higher
concentration in a defined time (‘‘heavy
up’’) of traditional media only, (2)
digital media only, and (3) a
combination of a ‘‘heavy up’’ along with
digital media. Each city will be nonrandomly assigned to a condition, i.e.,
the type (traditional or digital) and
sequence of additional advertisements.
Evaluation information will be collected
at four time points in each city (a
baseline survey plus up to three
additional surveys after each flight of
additional media). To reduce attrition
and eliminate time-in-sample bias that
would artificially increase measures of
campaign recognition, we will use
address-based, cross-sectional sampling
methods to randomly select respondents
for each survey. The address-based
sampling will also increase the
likelihood that respondents live within
the cities where the media campaigns
are implemented. Potential respondents
will receive an advance letter that
describes the study and provides a link
to the survey Web site. The total number
of respondents in each study location is
approximately 2,424.
Results of this evaluation study will
be used to inform CDC, policymakers,
prevention practitioners, researchers,
and the general U.S. population about
the reach and impact of the Inside
Knowledge gynecologic health
awareness campaign, and to inform the
development and implementation of
future health communication efforts.
OMB approval is requested for one
year. The same survey instrument will
be used for all information collection.
Participation is voluntary and there
are no costs to respondents other than
their time.

National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
In 2006, Congress passed The
Gynecologic Cancer Education and
Awareness Act (Pub. L. 111–324,
‘‘Johanna’s Law’’) authorizing CDC to
launch and evaluate a public health
information campaign regarding
gynecological cancers. The campaign,
entitled ‘‘Inside Knowledge: Get the
Facts About Gynecologic Cancer,’’ seeks
to increase women’s intentions to seek
medical attention for persistent
symptoms that could be indicative of
some of gynecological cancers, yet may
sometimes be ignored or simply
overlooked by women. The campaign is
managed by the Division of Cancer
Prevention and Control (DCPC) at the
Centers for Disease Control and
Prevention (CDC).
CDC plans to evaluate the Inside
Knowledge campaign by collecting
information from members of its target
audience: adult women (ages 40–65) in
the United States. Information will be
collected through self-administered,
Web-based surveys. Survey items will
include measures of audience recall of
the campaign; perceptions of campaign
messages; gynecologic health related
knowledge, attitudes, and beliefs;
intentions to seek care for symptoms
associated gynecologic cancers; and
sociodemographic characteristics.
Specifically, this information collection
will allow CDC to assess exposure to
campaign efforts and assess whether
women who were exposed to the
campaign have higher awareness of the
campaign, higher knowledge of
gynecological cancers, and greater
intentions to seek medical attention for
gynecologic cancer symptoms and/or to
discuss symptoms with their doctor.
The evaluation will also examine
whether women’s awareness of the
campaign differs by channel of delivery.
To conduct the evaluation, we will
augment the national Inside Knowledge
campaign with an additional paid media
campaign in two cities. Cities will be
selected based on the following criteria:
(1) Incidence/prevalence of gynecologic

tkelley on DSK3SPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondents

Form name

Women Ages 45–60 in City 1 ...........
Women Ages 45–60 in City 2 ...........

Women’s Health Survey ..................
Women’s Health Survey ..................

VerDate Mar<15>2010

17:24 Feb 25, 2014

Jkt 232001

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

2,424
2,424

E:\FR\FM\26FEN1.SGM

1
1

26FEN1

Avgerage
burden per
response
(in hr)
20/60
20/60

Total burden
(in hr)
808
808

10811

Federal Register / Vol. 79, No. 38 / Wednesday, February 26, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name

Number of
respondents

Number of
responses per
respondent

Avgerage
burden per
response
(in hr)

...........................................................

........................

........................

........................

Type of respondents

Total ...........................................

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04135 Filed 2–25–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

tkelley on DSK3SPTVN1PROD with NOTICES

Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 11:00 p.m.–2:00 p.m.,
Eastern Time, March 19, 2014.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public. The public
is welcome to submit written comments
in advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the
passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific

VerDate Mar<15>2010

17:24 Feb 25, 2014

Jkt 232001

validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2015.
Purpose: This Advisory Board is
charged with a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Discussed: The agenda
for the conference call includes: Final
Vote Tally for Joslyn Manufacturing
Plant SEC Petition Action;
Subcommittee and Work Group
Updates; SEC Petition Evaluations
Update for the April 2014 Advisory
Board Meeting; Plans for the April 2014
Advisory Board Meeting; and Advisory
Board Correspondence.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Designated
Federal Official, NIOSH, CDC, 1600
Clifton Road NE., Mailstop E–20,
Atlanta, Georgia 30333, Telephone (513)
533–6800, Toll Free 1–800–CDC–INFO,
Email [email protected].
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the

PO 00000

Frm 00049

Fmt 4703

Sfmt 4703

Total burden
(in hr)
1,616

Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–04085 Filed 2–25–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
9:00 a.m.–5:30 p.m. EST, March 27,
2014
8:00 a.m.–12:00 p.m. EST, March 28,
2014
Place: Centers for Disease Control and
Prevention, 4770 Buford Highway,
Chamblee Building 107 1A/1B/1C,
Atlanta, Georgia 30341
Status: The meeting is open to the
public, for in-person or distance
participation, limited only by the space
and phone lines available. For offsite
participation, call (1) toll free: 888–989–
8135 Participant passcode 4798; or (2)
by Net Conference at URL https://
www.mymeetings.com/nc/join/
Conference number: PW4485905
Audience passcode: 4798; or (3) join the
meeting directly at: https://
www.mymeetings.com/nc/
join.php?i=PW4485905&p=4798&t=c.
Participants outside of the U.S. may
join by calling toll free 1–415–228–4965
Participant passcode: 4798.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly

E:\FR\FM\26FEN1.SGM

26FEN1